tiprankstipranks
Trending News
More News >
SciDev Ltd (AU:SDV)
ASX:SDV

SciDev Ltd (SDV) AI Stock Analysis

Compare
8 Followers

Top Page

AU:SDV

SciDev Ltd

(Sydney:SDV)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 5.2)
Rating:50Neutral
Price Target:
AU$0.21
▼(-55.43% Downside)
Action:ReiteratedDate:03/24/26
The score is held up by an improving (but uneven) financial profile and a low-leverage balance sheet, but it is weighed down by weak technicals (broad downtrend and negative momentum) and limited valuation support due to loss-making/unstable earnings and no dividend data.
Positive Factors
Conservative balance sheet
Low leverage (debt-to-equity ~0.13) and stable equity provide durable financial flexibility. This reduces refinancing risk, supports funding for strategic initiatives (channel shift, R&D), and allows the company to absorb cyclical industry shocks without jeopardising operations.
Multi-year revenue scaling and improving gross margin
Sustained top-line growth over several years and a rebound in gross margin to ~32% indicate improving product-market fit and operational leverage. If managed, this structural scaling supports higher future operating cash generation and margin sustainability beyond short-term cycles.
High recurring sales and strategic turnaround actions
A recurring revenue base (>50%) plus a formal turnaround plan (channel-partner model, customer diversification, R&D and cross-selling) are structural levers to stabilise margins and scale distribution. These measures can sustainably raise recurring, higher-margin sales over the medium term.
Negative Factors
Inconsistent profitability
Return to a net loss in 2025 and historically uneven earnings undermine predictability of cash returns and reinvestment capacity. Structural earnings volatility complicates long-term planning, reduces investor confidence, and limits ability to commit to sustained shareholder distributions.
Weakened cash generation
A sharp decline in operating and free cash flow reduces the firm's internal funding for capex, R&D and working capital. Persistently weaker cash conversion increases reliance on external funding and constrains the company's ability to execute its turnaround without dilutive or costly financing.
Operational exposure and margin pressure
Reliance on Energy Services schedules and overseas projects exposes margins to customer timing and cost volatility. These structural execution risks can persist across quarters, making margin recovery uncertain and necessitating ongoing operational discipline and diversification to stabilise earnings.

SciDev Ltd (SDV) vs. iShares MSCI Australia ETF (EWA)

SciDev Ltd Business Overview & Revenue Model

Company DescriptionSciDev Limited engages in supply of process control, professional services, equipment design and construction, and chemistry in Australia and the United States. The company offers coagulants and flocculants in powder and liquid form under the MaxiFlox and MaxiDry name; engineering and process control; chemistry products for applications, including thickening, filtration, centrifuging, friction reduction, shale inhibition, rheology control, and carrier fluids; chemical batching, storage, and dosage systems; engineering solutions and technologies under the TrueMud and OptiFlox name; friction reducers under the DrySlik, WetSlik, and CarrySlik names; and dynamic shears. It serves water and wastewater treatment, mining and minerals processing, oil and gas, construction, food processing, dairy, power generation, personal products and cosmetics manufacturing, paper and cardboard manufacturing, and paint manufacturing industries. The company was formerly known as Intec Limited and changed its name to SciDev Limited in March 2017. SciDev Limited was incorporated in 1973 and is headquartered in Kings Park, Australia.

SciDev Ltd Financial Statement Overview

Summary
Strong multi-year revenue scaling and improved gross margin (~32% in 2025) support the score, and the balance sheet is conservatively levered (debt-to-equity ~0.13). However, earnings are inconsistent (back to a small net loss in 2025) and cash conversion weakened sharply with free cash flow dropping to ~A$0.8m from ~A$4.5m in 2024.
Income Statement
55
Neutral
Revenue scaled materially over the period (from ~A$18m in 2020 to ~A$104m in 2025), but the growth path is volatile and most recently turned negative (-5.0% in 2025). Profitability has improved from deep losses in 2020 to mostly positive operating results, with gross margin rebounding to ~32% in 2025; however, net income slipped back to a small loss in 2025 (net margin ~-0.8%) after a profitable 2024 (~2.0%). Overall, the business shows improving operating profile, but earnings consistency remains a key weakness.
Balance Sheet
72
Positive
The balance sheet looks conservatively levered, with low debt relative to equity (debt-to-equity ~0.13 in 2025; generally ~0.06–0.16 across the period). Equity has been maintained around A$48–50m in recent years, supporting financial flexibility. The main drawback is uneven returns to shareholders (return on equity negative in 2025 and several prior years), indicating that despite low leverage, profitability is not yet reliably strong.
Cash Flow
46
Neutral
Cash generation weakened notably in 2025: operating cash flow fell to ~A$2.9m from ~A$6.5m in 2024, and free cash flow dropped to ~A$0.8m from ~A$4.5m (a sharp decline). While operating cash flow is positive in the last three years (2023–2025), it was negative in 2021–2022, highlighting variability. Free cash flow remains positive in 2025, but the step-down versus 2024 reduces confidence in near-term cash conversion stability.
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue101.34M103.50M109.09M89.72M55.60M42.52M
Gross Profit18.57M33.39M33.97M6.83M3.69M1.37M
EBITDA3.28M5.91M7.65M4.11M1.13M1.88M
Net Income-2.95M-878.00K2.17M-339.00K-616.00K3.45M
Balance Sheet
Total Assets71.24M75.23M72.01M67.37M71.16M56.15M
Cash, Cash Equivalents and Short-Term Investments7.52M9.68M9.43M7.73M14.06M7.01M
Total Debt6.61M6.26M5.13M3.48M2.90M5.13M
Total Liabilities23.81M25.18M21.78M19.35M22.32M24.54M
Stockholders Equity47.43M50.05M50.24M48.02M48.84M31.61M
Cash Flow
Free Cash Flow-2.13M785.00K4.48M522.00K-3.83M-1.92M
Operating Cash Flow-1.00K2.87M6.48M4.81M-1.31M-1.32M
Investing Cash Flow366.00K-2.35M-3.71M-8.39M-6.65M-2.49M
Financing Cash Flow-3.31M-390.00K-1.06M-2.83M14.99M6.34M

SciDev Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.46
Price Trends
50DMA
0.33
Negative
100DMA
0.38
Negative
200DMA
0.35
Negative
Market Momentum
MACD
-0.03
Negative
RSI
26.92
Positive
STOCH
1.30
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:SDV, the sentiment is Negative. The current price of 0.46 is above the 20-day moving average (MA) of 0.24, above the 50-day MA of 0.33, and above the 200-day MA of 0.35, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 26.92 is Positive, neither overbought nor oversold. The STOCH value of 1.30 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:SDV.

SciDev Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
55
Neutral
AU$34.67M-2.92-82.31%7.08%33.70%
50
Neutral
AU$38.97M-10.44-6.05%-5.37%-140.00%
46
Neutral
AU$19.50M-2.95-97.12%52.66%
44
Neutral
AU$21.89M-0.76223.49%-32.85%28.00%
43
Neutral
AU$22.87M-1.69483.00%340.27%19.44%
43
Neutral
AU$122.96M-1.24-73.16%16.47%29.53%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:SDV
SciDev Ltd
0.21
-0.22
-51.19%
AU:AJX
Alexium International Group
0.01
0.00
0.00%
AU:DTZ
Dotz Nano Limited
0.03
-0.04
-52.86%
AU:SPN
Sparc Technologies Ltd
0.17
-0.01
-8.33%
AU:CXL
Calix Ltd.
0.57
0.20
54.05%
AU:CG1
Carbonxt Group Ltd.
0.08
0.03
48.15%

SciDev Ltd Corporate Events

SciDev director Mike Utsler lifts stake with on‑market share purchase
Mar 9, 2026

SciDev Ltd has disclosed a change in the shareholding of director Mike Utsler, who increased his direct holding in the company through on-market purchases executed between 4 and 6 March 2026. The transactions involved acquiring 150,000 fully paid ordinary shares at prices between A$0.23 and A$0.235, lifting his stake from 117,111 to 267,111 shares and signaling additional personal commitment to the company without any disposals or related contract changes.

The company confirmed that the trades were conducted as standard on-market transactions outside any closed trading period, meaning no special clearances were required under its governance rules. While the notice is primarily procedural, the increased holding by a serving director may be interpreted by investors as a sign of confidence in SciDev’s prospects, though no explicit commentary on strategy or outlook accompanied the filing.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.24 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev director Dan O’Toole lifts indirect shareholding with on-market purchase
Feb 27, 2026

SciDev Ltd has disclosed a change in director Dan O’Toole’s relevant interest in the company’s securities, reflecting an increase in his indirect shareholding through Huon Road Pty Ltd . The disclosure, lodged with the ASX, details that O’Toole acquired 106,000 fully paid ordinary shares on-market at $0.2293 per share, lifting his indirect holding to 372,000 shares while his direct holding remains 62,111 shares.

The on-market purchase signals a higher personal financial exposure by the director to SciDev’s equity, which may be interpreted by investors as a sign of confidence in the company’s prospects. The transaction occurred outside a closed period and required no special trading clearance, indicating that it was conducted under normal trading conditions within the company’s governance framework.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.23 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Hit by Energy Disruptions and Cost Pressures in First Half FY26
Feb 25, 2026

SciDev Ltd reported a challenging first half of FY26, with revenue slipping to $47.9 million from $49.9 million a year earlier and gross margins contracting to 28%. Management attributed the weaker performance primarily to disruption in fracturing schedules within its Energy Services division and higher costs in its Overseas Water Technologies operations, which reduced reported EBITDA to $0.4 million and underlying EBITDA to $1.1 million, despite maintaining a net cash position of $4.4 million and 54% of revenue from recurring sources.

The results underscore operational headwinds in key business lines but also highlight the resilience provided by the company’s recurring revenue base and net cash position. Investors will focus on how effectively SciDev can stabilise costs in its overseas operations and restore growth in Energy Services activity to support a recovery in margins and earnings over the remainder of the financial year.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.35 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev outlines turnaround plan after challenging first half
Feb 25, 2026

SciDev reported a weaker first half of FY26, with revenue slipping to A$47.9 million and underlying EBITDA falling to A$1.1 million, as a frac schedule change at a key U.S. energy customer hit xSlik® sales and international Water Technologies investments outpaced revenues. In response, the company is shifting its international water business to a lower-cost channel partner model, diversifying its Energy Services customer base, and capitalising on record Process Chemistry results and a profitable APAC Water Technologies arm to drive second-half revenue and earnings growth.

Management has highlighted improving quarterly momentum, cost reductions at corporate level, and a strategy to expand higher-margin and recurring revenue streams, which now account for more than half of group sales. These moves, alongside R&D for next-generation specialty chemicals and cross-selling water technologies across its global customer base, aim to strengthen SciDev’s competitive position as it pursues its ambition to be a leading water technology provider to the energy and mining sectors.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.35 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Swings to Deeper Half-Year Loss on Modest Revenue Decline
Feb 25, 2026

SciDev Limited reported half-year revenues of $47.9 million for the period ended 31 December 2025, down 4% from a year earlier, while its net loss after tax widened sharply to $2.14 million from $68,000. The result pushed basic and diluted earnings per share to a loss of 1.13 cents, compared with a 0.04 cent loss previously, and the company again did not declare a dividend.

The deterioration in earnings, despite only a modest decline in revenue, points to rising costs, margin pressure or one-off impacts weighing on profitability during the half. Net tangible assets per share also eased to 12.16 cents from 13.32 cents at 30 June 2025, suggesting a slight weakening in balance sheet backing for shareholders and underscoring a more challenging operating environment.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.35 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev sets date for 1H FY26 results and investor webcast
Feb 23, 2026

SciDev Ltd will release its first-half FY26 financial results before the market opens on 26 February 2026 and will host an investor webcast the same morning. The online briefing, led by Managing Director and CEO Seán Halpin and CFO Todd Scott, will outline the company’s 1H FY26 operational highlights and business activities and include a Q&A session for investors and shareholders.

The event underscores SciDev’s efforts to maintain active engagement with the market as it advances its portfolio of water treatment technologies across resource and infrastructure industries. Stakeholders will be looking to the presentation for insights into trading performance, project momentum and how its solutions are being adopted to address water reuse, efficiency and environmental challenges in key industrial sectors.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.35 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev switches auditors to BDO for 2026 oversight
Feb 4, 2026

SciDev named BDO Audit as its new external auditor after a competitive tender and ASIC-approved resignation of Ernst & Young, noting no disagreements with the outgoing firm. The board expects BDO to serve through the 2026 AGM, reinforcing governance stability and signaling continuity in financial oversight ahead of the next reappointment vote.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.39 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026